NASDAQ:ALDX

Aldeyra Therapeutics Stock Forecast

etoro logo Buy ALDX
*Your capital is at risk
$1.51
-0.0400 (-2.58%)
At Close: Aug 10, 2026

Should you buy ALDX stock?

Last updated:

Based on market data through , StockInvest.us rates Aldeyra Therapeutics (ALDX) as a Sell Candidate with a technical score of -4.52 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 5.03%
  • 3-month trend forecast Down 0.32%
  • Sell Candidate -4.52
AI Analysis AI Analysis of ALDX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALDX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Aldeyra Therapeutics stock price ended at $1.51 on Monday, after losing 2.58%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 06, 2026 Loss -5.03%

The Aldeyra Therapeutics stock price fell by -2.58% on the last day (Monday, 10th Aug 2026) from $1.55 to $1.51. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.64% from a day low at $1.51 to a day high of $1.57. The price has fallen in 7 of the last 10 days and is down by -4.73% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -304 thousand shares and in total, 867 thousand shares were bought and sold for approximately $1.31 million.

Given the current horizontal trend, you can expect Aldeyra Therapeutics stock with a 90% probability to be traded between $1.51 and $2.42 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ALDX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aldeyra Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.55 and $1.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -37.86%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Aldeyra Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0550 between high and low, or 3.64%. For the last week the stock has had daily average volatility of 4.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALDX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Aldeyra Therapeutics to open at $1.53, and during the day (based on 14 day Average True Range), to move between $1.45 and $1.57, which gives a possible trading interval of +/-$0.112 (+/-7.67%) up or down from last closing price. If Aldeyra Therapeutics takes out the full calculated possible swing range there will be an estimated 7.67% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.55, some $0.0400 (2.65%) from the current price of $1.51, our system finds the risk reward not very attractive.

Is Aldeyra Therapeutics stock A Buy?

Aldeyra Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.519 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.53 ( 1.21%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALDX Performance

Trading levels for ALDX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.58 4.86%
R2 1.56 3.47%
R1 1.55 2.61%
Price 1.51
S1 1.51 -0.177%
S2 1.49 -1.04%
S3 1.47 -2.43%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.83 21.19%
R2 1.72 13.91%
R1 1.55 2.65%
Price 1.51
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Aldeyra Therapeutics Stock and on which exchange is it traded?
The symbol for Aldeyra Therapeutics is ALDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aldeyra Therapeutics Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Aldeyra Therapeutics (ALDX) as a Sell Candidate with a technical score of -4.52 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 06, 2026, the price has fallen 5.03%. The current 3-month trend forecast projects a fall of 0.32%.

How to buy Aldeyra Therapeutics Stock?
Aldeyra Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aldeyra Therapeutics Stock.

What's the current price of Aldeyra Therapeutics Stock?
As of the end of day on the Aug 10, 2026, the price of an Aldeyra Therapeutics (ALDX) share was $1.51.

What is the 52-week high and low for Aldeyra Therapeutics Stock?
The 52-week high for Aldeyra Therapeutics Stock is $6.18 and the 52-week low is $1.07.

What is the market capitalization of Aldeyra Therapeutics Stock?
As of the Aug 10, 2026, the market capitalization of Aldeyra Therapeutics is 91.085M.

When is the next earnings date for Aldeyra Therapeutics?
The upcoming earnings date for Aldeyra Therapeutics is Nov 12, 2026.
Click to get the best stock tips daily for free!
ABOUT ALDEYRA THERAPEUTICS
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE